MAPT and Alzheimer disease: However, cannabinoids exhibit a pleiotropic activity, simultaneously addressing key stages in AD, such as aberrant processing of Aβ and tau, neuroinflammation, excitotoxicity, mitochondrial dysfunction, and oxidative stress.